Beneficial effects of MGL-3196 and BAM15 combination in a mouse model of fatty liver disease.
Mingyan ZhouCatherine LiFrances L ByrneCalum S VancuylenburgEllen M OlzomerAdam HargreavesLindsay E WuNicholas A ShackelWebster L SantosKyle Lee HoehnPublished in: Acta physiologica (Oxford, England) (2024)
MGL + BAM15 treatment had overall better efficacy to improve metabolic outcomes in mice fed GAN diet than either monotherapy alone. These data warrant further investigation into combination therapies of THR-β agonists and mitochondrial uncouplers for the potential treatment of disorders related to fatty liver, obesity, and insulin resistance.